Review demonstrates expanding applications and surmountable technical barriers of dried blood spots in clinical testing, suggesting technological advances will drive widespread adoption.
DBS provide a wide range of potential applications that extend beyond the reach of traditional samples. Current limitations are serious but not intractable. Technological advancements will likely continue to minimize constraints around DBS adoption.
No takes yet. Share an insight, caveat, or question.
Freeman et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: